Stockreport

Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates [Yahoo! Finance]

Aytu BioPharma, Inc.  (AYTU) 
NASDAQ:AMEX Investor Relations: aytubio.com/investors/stock-information
PDF This compares to a loss of $0.28 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -30 [Read more]